December 23, 2020
In this week's episode, MHE's Senior Editor Peter Wehrwein spoke with Sumit Dutta, Optum Rx chief medical officer. The two spoke about COVID-19 vaccines and how the pharmacy benefit market responded to the pandemic.
December 12, 2020
The five states have moved to prohibit accumulators and maximizers as the federal government takes a hands-off approach, according to John “Jack” S. Linehan, a lawyer at Epstein Becker Green, who is featured in this second part of a two-part video series.
December 09, 2020
John “Jack” S. Linehan, a lawyer at Epstein Becker Green, is featured in the first part of a two-part video series on copay accumulators and maximizers.
November 23, 2020
Health plans build strategies to ensure their beneficiaries have easy access to and receive vital immunizations.
October 15, 2020
Featured speaker at the 4th Annual PBMI Specialty Rx Forum on October 16 discusses theme of the meeting.
October 07, 2020
In this week’s episode of Tuning Into the C-Suite, MHE's Briana Contreras spoke with Denise Basow, president and CEO of Clinical Effectiveness at Wolters Kluwer. Briana and Basow discussed the importance of uniting prescribers and pharmacists at the point of care and how this form of care can create more efficient and effective operations within health systems.
September 29, 2020
Can data mined from EHRs match that from the gold standard, randomized clinical trials?
September 02, 2020
The 2020 meeting, presented in a virtual format from its original host city of Amsterdam, The Netherlands, had lots of important science and a record number of viewers.
July 31, 2020
As it has done with so much else in healthcare, COVID-19 dominated our 2020 annual pharmacy survey. The disease was addressed in 10 of our 13 areas we covered, either within the question itself or as a possible answer. Third of three parts. See more in our Surveys tab.
July 30, 2020
As it has done with so much else in healthcare, COVID-19 dominated our 2020 annual pharmacy survey. The disease was addressed in 10 of our 13 areas we covered, either within the question itself or as a possible answer. Second of three parts. See more in our Surveys tab.